Form 4: Columbia Financial, Inc. Executive Jenifer White Walden Reports Stock Acquisition and Option Holdings
SEC Form 4 Filing
EVP & CHRO of Columbia Financial, Inc., Jenifer White Walden, reports acquisition of common stock through a stock-based deferral plan and holds various stock options and awards.
Summary
- On September 20, 2024, Jenifer White Walden, EVP & CHRO of Columbia Financial, Inc., reported acquiring common stock through a stock-based deferral plan at a price of $17.42 per share.
- The transaction resulted in Ms. Walden beneficially owning 1,645.3439 shares indirectly through the Stock-Based Deferral Plan.
- Ms. Walden also directly owns 1,359 shares of common stock.
- Additionally, Ms. Walden indirectly owns shares through an ESOP (982 shares), SERP (45 shares), SIM (14 shares), Stock Award (1,298 shares), Stock Award II (7,817 shares), and Stock Award III (7,597 shares).
- Ms. Walden holds stock options to buy 5,540 shares at $20.54 (exercisable from October 31, 2023), 6,203 shares at $15.94 (exercisable from May 1, 2024), and 5,107 shares at $16.49 (exercisable from March 6, 2025).
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral. It simply reports transactions and holdings.
Industry Context
This filing is a routine disclosure related to executive compensation and holdings, typical for publicly traded companies. It provides transparency into the equity-based compensation structure for Columbia Financial's executives.
Comparison to Industry Standards
- Equity-based compensation, including stock options and awards, is a common practice among publicly traded financial institutions like Columbia Financial, Inc.
- The vesting schedules and exercise prices of the stock options appear to be within the typical range for executive compensation packages in the banking industry.
- Companies like Bank of America, JP Morgan Chase, and Wells Fargo also utilize similar equity incentive plans to align executive interests with shareholder value.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and alignment of interests.
- Employees participating in the ESOP and stock-based deferral plan are indirectly impacted by the value of the company's stock.
Key Dates
| Date | Description |
|---|---|
| 10/31/2023 | Commencement of vesting for stock options with an exercise price of $20.54. |
| 05/01/2024 | Commencement of vesting for stock options with an exercise price of $15.94 and Stock Awards II. |
| 09/20/2024 | Date of the reported transaction involving the acquisition of common stock through a stock-based deferral plan. |
| 09/24/2024 | Date of signature by Power of Attorney. |
| 03/06/2025 | Commencement of vesting for stock options with an exercise price of $16.49 and Stock Awards III. |
| 03/06/2034 | Expiration date for stock options with an exercise price of $16.49. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.